Effect of intralesional and systemic BCG-application or a combined cyclophosphamide/BCG treatment on experimental bladder cancer
Authors:
- 1 January 1979
- journal article
- Published by Springer Nature in Urological Research
- Vol. 7 (2) , 71-78
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Induction of transitional cell carcinoma of the urinary bladder in rats by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamideUrological Research, 1978
- Effect of BCG treatment on the evolution of cell-mediated immunity in mice bearing transplantable syngeneic tumorsEuropean Journal of Cancer (1965), 1977
- Therapeutic effect of intratumoral injection of BCG and other substances in rats and miceInternational Journal of Cancer, 1975
- Histological and combined chemoimmunostimulation therapy studies against a murine leukemiaInternational Journal of Cancer, 1975
- Immune manipulation by BCG administered before or after cyclophosphamide for chemo-immunotherapy of L1210 leukaemiaEuropean Journal of Cancer (1965), 1974
- Chemotherapy of experimental transitional-cell carcinomaUrology, 1974
- Factor time for active immunotherapy after cytoreductive chemotherapyEuropean Journal of Cancer (1965), 1974
- Effects of BCG on various facets of the immune response against polyoma tumors in ratsInternational Journal of Cancer, 1973
- Active Immunotherapy with Corynebacterium parvum and Chemotherapy in Murine FibrosarcomasBMJ, 1970
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969